Chemical Compound

bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate

CAS Registry Number 706782-28-7
bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate 结构式
Primary record

bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate

库存
9,941 克
纯度
98.5 %
CAS
706782-28-7

化合物标识与属性

CAS
706782-28-7
PubChem CID
11672491
SMILES
CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
Canonical SMILES
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O

名称与同义词

  • Pimavanserin tartrate
  • Nuplazid
  • UNII-NA83F1SJSR
  • Pimavanserin
  • 706782-28-7
  • pimavanserin hemitartrate
  • Nuplazide (TN)
  • NA83F1SJSR
  • Pimavanserin tartrate?
  • ACP-103
  • ACP-103 hemitartrate
  • Pimavanserin tartrate [USAN]
  • RefChem:59075
  • Pimavanserin tartaric acid
  • ACP 103
  • PimavanserintartrateorACP103
  • 706782-28-7 (tartrate)
  • Pimavanserin tartrate (USAN)
  • CHEBI:133014
  • DTXSID50220958
  • Pimavanserin Impurity reference
  • orb1300322
  • SCHEMBL29384707
  • DTXCID80143449
  • MFCD09970919
  • Pimavanserin Dihydroxysuccinate(2:1)
  • RGSULKHNAKTFIZ-CEAXSRTFSA-N
  • HMS3886L06
  • PIMAVANSERIN TARTRATE [MI]
  • C54H74F2N6O10
  • s8183
  • AKOS027327334
  • PIMAVANSERIN TARTRATE [WHO-DD]
  • ACN-037476
  • CCG-270608
  • EBC-108072
  • CID11672491
  • AC-29901
  • AS-56699
  • BP164269
  • FP104271
  • Pimavanserin tartrate - Bio-X trade mark
  • SC-90507
  • PIMAVANSERIN TARTRATE [ORANGE BOOK]
  • LS-193533
  • FT-0701299
  • Pimavanserin tartrate, 99% - 250MG 250mg
  • D08969
  • A901390
  • Q27284759
  • (2R,3R)-2,3-dihydroxybutanedioic acid;1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
  • Bis(1-(4-Fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate
  • N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1)
  • Urea, N-((4-fluorophenyl)methyl)-N-(1-methyl-4-piperidinyl)-N'-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
  • 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea (2R,3R)-2,3-dihydroxysuccinate
  • 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea, ((2R,3R)-2,3-dihydroxysuccinate) (2:1)
  • (2R,3R)-2,3-Dihydroxybutanedioic acid--N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea (1/2)
  • (2R,3R)-2,3-dihydroxybutanedioic acid; bis(1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-{[4-(2-methylpropoxy)phenyl]methyl}urea)
  • (2R,3R)-2,3-dihydroxybutanedioic acid;1-[(4-fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)urea
  • 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea hemi((2R,3R)-2,3-dihydroxysuccinate)
  • bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate
  • Bis[1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-[4-(2-methylpropoxy)benzyl]urea] (2R,3R)-2,3-dihydroxybutanedioate
  • bis{N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea} (2R,3R)-2,3-dihydroxybutanedioate
  • N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide